Regeneron
Biotechnology company known for antibody discovery platforms and integrated R&D.
Typical Backgrounds
Types of experience professionals commonly develop
Roles Companies Often Recruit
Common roles when hiring Regeneron-caliber talent
- Principal Scientists
- Clinical Development Leaders
- Regulatory Affairs
- Medical Science Liaisons
- Bioinformatics Scientists
- Executive Leadership
Related Resources
Salary guides, hiring guides, market reports and case studies
Regeneron's reputation as an R&D-first biotech
Regeneron is one of the few large biotechs still run by its founding scientific leadership, and that continuity shows up in how the market reads its talent. Regeneron built its own antibody discovery platform (VelocImmune) and its own human genetics initiative, so its scientists tend to have deeper platform-level exposure than counterparts at companies that license or acquire external technology.
Recruits Lab consistently sees strong demand for Regeneron alumni in antibody discovery and human genetics/bioinformatics, since both groups reflect proprietary internal platforms that are hard to replicate quickly at a smaller company.
Org structure and titles that matter
Regeneron's R&D structure centers on Research (antibody discovery and genetics), Translational Sciences, and Clinical Development, with a Genetics Center that operates almost like an internal research institute. Titles worth knowing: Senior Director and Vice President of Research within a therapeutic area, Director of Human Genetics, Executive Director of Clinical Development, and Director of Regulatory Affairs.
Because Regeneron still runs discovery through commercialization internally for many programs, its Director-level scientists often carry broader end-to-end accountability than peers at companies that outsource more of the pipeline.
Hiring bar and interview process
Regeneron is known for a rigorous, scientifically intense interview process, often including a formal seminar presentation to the department for research scientist roles, followed by one-on-ones with multiple principal investigators. The company places heavy weight on original scientific contribution and hands-on lab or computational skill, even at senior levels.
Clinical and regulatory interviews are more standard panel formats but still probe deeply into trial design rationale and past regulatory interactions, reflecting the company's history of managing its own global filings for major products.
Compensation posture
| Level / Function | Typical Total Comp Range | Equity Form | Notes |
|---|---|---|---|
| Senior Director, Research (Antibody Discovery) | $260K–$330K | Regeneron RSUs | Strong internal promotion culture |
| Director, Human Genetics / Bioinformatics | $220K–$280K | Regeneron RSUs | Platform-specific skill is scarce externally |
| Executive Director, Clinical Development | $300K–$390K | Regeneron RSUs | Bonus target 25–30% |
| Director, Regulatory Affairs | $230K–$290K | Regeneron RSUs | Deep global filing experience |
| VP, Research | $380K–$480K | Regeneron RSUs plus long-term incentives | Long tenure typical before reaching this level |
Which profiles transfer well, and where
The most common big-pharma-to-biotech-startup move out of Regeneron is a Senior Director in antibody discovery or human genetics moving into a Chief Scientific Officer or VP Research role at a Series B or C biotech, trading Regeneron's internal platform depth for direct ownership of a smaller company's entire discovery strategy.
| Origin Team | Strengths | Best-Fit Destination | Watch-Outs |
|---|---|---|---|
| Antibody Discovery / VelocImmune Platform | End-to-end antibody engineering and platform thinking | Biotech building or licensing its own discovery engine | May expect more internal tooling support than a startup can offer |
| Human Genetics / Bioinformatics | Population-scale genetics analysis, target validation | Genomics-driven techbio or precision medicine startup | Startup datasets are often far smaller than Regeneron Genetics Center scale |
| Clinical Development, Ophthalmology/Immunology | Complex biologics trial design | Growth biotech advancing a first-in-class biologic | Fewer internal statistical resources at a smaller company |
| Regulatory Affairs | Global biologics filing experience | Biotech preparing its first BLA | Needs to operate with a leaner regulatory team |
How to recruit out of Regeneron
Motivators: desire for broader scientific ownership and equity upside, since Regeneron's internal promotion ladder is competitive and slow at the top. Blockers: genuine scientific pride in the VelocImmune and Genetics Center platforms, plus strong long-term incentive vesting that penalizes early exits.
Regeneron's Tarrytown, NY headquarters is largely on-site, which makes location a real filter; many candidates will only move for roles in the Northeast biotech corridor or fully remote research leadership positions. Counter-offers tend to focus on accelerated promotion and expanded scientific scope rather than just comp, since Regeneron knows cash alone rarely retains its top research talent.
Frequently asked questions
Why is Regeneron Genetics Center talent valuable to startups?
The Genetics Center has run one of the largest population-sequencing efforts in the industry, giving its bioinformatics and genetics scientists exposure to target validation at a scale most biotechs cannot replicate internally, making that experience valuable for genomics-driven startups.
How rigorous is Regeneron's research scientist interview process?
Very. Senior research roles typically include a formal seminar presentation to the department, followed by multiple one-on-one interviews with principal investigators who probe deeply into original scientific contributions and platform-level thinking, not just résumé claims.
What is the typical path from Regeneron to a startup CSO role?
A Senior Director or VP of Research at Regeneron, particularly from the antibody discovery or genetics organizations, commonly moves into a Chief Scientific Officer or VP Research role at a Series B–D biotech seeking platform-level scientific leadership.
Does Regeneron use non-competes or retention grants to keep senior scientists?
Regeneron relies primarily on long-term RSU vesting schedules and a strong internal promotion culture rather than aggressive non-compete enforcement, so most retention friction in a search comes from unvested equity and scientific loyalty rather than legal restriction.
What functions is Regeneron currently expanding?
Recruits Lab sees continued growth in ophthalmology and immunology clinical development, along with expanding genetics-driven target discovery work tied to the Regeneron Genetics Center's ongoing population studies.